Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 10.53

From 52W high−39.97%

Volume4.18M

Market capCNY 5.46B

P/E (TTM)11.6x

P/S (TTM)1.8x

Div yield3.79%

Key dataSep 18, 2026

Open

CNY 10.53

From 52W high

−39.97%

Volume

4.18M

Market cap

CNY 5.46B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

7.9x

P/E (TTM)

11.6x

RSI (14)

41.7

MomentumView details →

1D Return

−5.62%

YTD Return

−29.57%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

11.6x

EV/EBITDA

7.9x

EV/Sales

1.8x

P/S (TTM)

1.8x

P/B (TTM)

2.1x

ProfitabilityView details →

Gross Margin

71.59%

Net Margin

13.41%

EBITDA Margin

22.05%

ROE (TTM)

14.99%

ROA (TTM)

9.80%

Asset Turnover

0.74x

GrowthView details →

Revenue YoY

−0.85%

EPS YoY

−22.64%

FCF YoY

—

Revenue CAGR 3Y

+10.17%

EPS CAGR 3Y

+5.39%

EBITDA YoY

—

MomentumView details →

1D Return

−5.62%

YTD Return

−29.57%

1Y Return

−38.91%

RSI (14)

41.7

vs 50D SMA

−4.94%

vs 200D SMA

−19.65%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

3.73x

Quick Ratio

2.81x

Div Yield

3.79%

Div Rate

CNY 0.40

Div Growth 1Y

+27.81%

EarningsView details →

EPS (Actual)

CNY 0.21

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

3.01B

Net Income (TTM)

403.78M

Op. CF (TTM)

577.63M

Latest newsMore news →

Jiudian Pharmaceutical participated in the bidding for the 12th batch of national centralized drug procurement on July 31, 2026, and its two products, ferrous succinate tablets and indobufen tablets, are provisionally selected, with nationwide supply.48d ago

Similar companies

兄弟科技002562.SZ 丰元股份002805.SZ 金财互联002530.SZ 新北洋002376.SZ ST晨鸣000488.SZ 通合科技300491.SZ Find similar companies →

Latest newsMore news →

Jiudian Pharmaceutical participated in the bidding for the 12th batch of national centralized drug procurement on July 31, 2026, and its two products, ferrous succinate tablets and indobufen tablets, are provisionally selected, with nationwide supply.48d ago